Short Report: Campylobacter fetus Bacteremia in an Immunocompetent Traveler

Campylobacter fetus bacteremia is a rare human infection that occurs almost exclusively in the setting of advanced age, immunosuppression, human immunodeficiency virus infection, alcoholism, or recent gastrointestinal surgery. This report of C. fetus bacteremia in a 39-year-old immunocompetent traveler who ate raw beef identifies C. fetus as a potential emerging pathogen in normal hosts. Campylobacter fetus is a common pathogen of cattle, sheep, and other ungulates. Human C. fetus infection is associated with consumption of raw or undercooked meat, unpasteurized milk, and other uncooked foods. 1 Although the Campylobacter genusisacommoncauseofgastrointestinalsymptomsinhumans, C. fetus bacteremia is very rare, occurring almost exclusively in the setting of advanced age, immunosuppression, human immunodeficiency virus (HIV) infection, alcoholism, or recent gastrointestinal surgery. 2 We report a case of C. fetus bacter- emia in an immunocompetent patient after travel to Ethiopia. A 39-year-old Ethiopian male presented with fever, hypoten- sion, tachycardia, watery diarrhea, lower back and hip pain, nausea, and vomiting. His symptoms began 2 days after return- ing from a trip to Addis Ababa, Ethiopia, where he stayed within the city for 3 months to visit his family. He reported eating uncooked beef and raw honey during his trip. He did not take malarial prophylaxis because of the high elevation of the area. He reported consuming two to three alcoholic beverages a week, and his medical history was significant only for mild hepatic steatosis, treated latent tuberculosis infection 15 years before, and obstructive sleep apnea. His initial hospital treat- ment included intravenous fluid resuscitation as well as intrave- nous vancomycin and piperacillin/tazobactam. An abdominal computed tomography scan without contrast revealed a dif- fusely distended colon with multiple air-fluid levels. The patient was transitioned to oral ciprofloxacin and metronidazole as he clinically improved. Blood cultures were positive for C. fetus on day 3 of hospitalization. Because fluoroquinolone resistance in C. fetus can exceed 30%, 3 antibiotic therapy was empirically changed to azithromycin, and the patient was discharged to complete a 14-day total antibiotic course. Other laboratory testing revealed three negative malaria smears, normal immuno- globulin levels, a negative serum HIV enzyme-linked immuno- sorbent assay, negative anti-Hepatitis C virus antibodies, and positive Hepatitis B surface antibodies. Reports on the incidence of C. fetus bacteremia vary. Of 183 episodes of Campylobacter bacteremia in 23 French hos- pitals between 2000 and 2004, 53% were caused by C. fetus. 3 Other investigators have identified C. fetus less frequently; 19% of 71 Campylobacter bacteremia episodes were C. fetus in one Spanish teaching hospital over 23 years, and 8.6% of 394 Campylobacter bacteremia cases were C. fetus in an English report spanning 11 years. 4,5 Although the Centers for Disease Control and Prevention Foodborne Outbreak Online Database (FOOD) reported only one confirmed case of C. fetus infection from 1998 to 2011, US cases may be under- reported. 6 Cases of C. fetus bacteremia are more likely to occur in patients with advanced age, comorbid illness, or immunodeficiency. 3 Our case shows that systemic infection from this organism can occur in immunocompetent individ- uals and highlights the importance of pre-travel education on sanitary food practices.